Search hospitals > North Carolina > Greensboro
PharmQuest
Claim this profileGreensboro, North Carolina 27408
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Migraine
Conducts research for Osteoarthritis
Conducts research for Obesity
127 reported clinical trials
1 medical researcher
Summary
PharmQuest is a medical facility located in Greensboro, North Carolina. This center is recognized for care of Diabetes, Type 2 Diabetes, Migraine, Osteoarthritis, Obesity and other specialties. PharmQuest is involved with conducting 127 clinical trials across 79 conditions. There are 1 research doctors associated with this hospital, such as Alexander Vance Murray.Top PIs
Clinical Trials running at PharmQuest
Type 2 Diabetes
Diabetes
Obesity
Chronic Kidney Disease
Giant Cell Arteritis
Cardiovascular Disease
Coronary Artery Disease
Coronary Heart Disease
Flu
Acute Coronary Syndrome
Orforglipron vs Semaglutide
for Type 2 Diabetes
The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes and inadequate glycemic control with metformin.The study will last around 61 weeks.
Recruiting2 awards Phase 33 criteria
Weekly vs Daily Insulin
for Type 2 Diabetes
This study compares insulin icodec, a new insulin taken once a week, to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 2 diabetes. Participants will either get insulin icodec or insulin glargine. Which treatment participants get is decided by chance. Insulin icodec is the new medicine being tested, while insulin glargine is already approved and can be prescribed by doctors. Participants will get one injection of insulin icodec once a week, or one injection of insulin glargine once a day, depending on the treatment group participants are assigned into. Participants will use a pen with a small needle to inject the medicine under participants skin into participants thigh, upper arm or stomach.The study will last for about 9 months, but participants will only be taking the study medicine for 6 months.
Recruiting2 awards Phase 3
Orforglipron
for Type 2 Diabetes and Obesity
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at increased cardiovascular risk. The study will last approximately 2 years may include up to 27 visits.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at PharmQuest?
PharmQuest is a medical facility located in Greensboro, North Carolina. This center is recognized for care of Diabetes, Type 2 Diabetes, Migraine, Osteoarthritis, Obesity and other specialties. PharmQuest is involved with conducting 127 clinical trials across 79 conditions. There are 1 research doctors associated with this hospital, such as Alexander Vance Murray.